PuSH - Publication Server of Helmholtz Zentrum München

134 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
61.
Mu, X.* et al.: Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J. Clin. Invest. 125, 3891-3903 (2015)
62.
Neff, F.* et al.: Notch triggers myeloid reprogramming in murine pancreatic cancer. Eur. J. Cancer 51, S2 (2015)
63.
O'Connor, T. ; Borsig, L.* & Heikenwälder, M.: CCL2-CCR2 signaling in disease pathogenesis. Endocr. Metab. Immune Disord. Drug Targets 15, 105-118 (2015)
64.
Protzer, U. et al.: Molecular detection of Hepatitis E Virus (HEV) in liver biopsies after liver transplantation. Mod. Pathol. 28, 523-532 (2015)
65.
Ringelhan, M. ; Protzer, U. ; O'Connor, T.* & Heikenwälder, M.: The direct and indirect role of HBV in liver cancer: Prospective markers for HCC-screening and potential therapeutic targets. J. Pathol. 235, 355-367 (2015)
66.
Saito, Y.* et al.: Development of human hemato-lymphoid system in human cytokine knock-in RAG2-/-IL2RG-/- mice engrafted with peripheral blood mobilized CD34+ cells. Exp. Hematol. 43, S92 (2015)
67.
Seleznik, G.M.* et al.: The lymphotoxin β receptor is a potential therapeutic target in renal inflammation. Kidney Int. 89, 113–126 (2015)
68.
Seubert, B.* et al.: TIMP-1 creates a pre-metastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology 61, 238-248 (2015)
69.
Seubert, B.* et al.: Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization. Int. J. Cancer 136, 2304-2315 (2015)
70.
Sprinzl, M.F. et al.: Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. J. Hepatol. 62, 863-870 (2015)
71.
Weber, A.* ; O'Connor, T.* & Heikenwälder, M.: Next generation of preclinical liver cancer models. Clin. Cancer Res. 21, 4254-4256 (2015)
72.
Weber, J.* et al.: CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice. Proc. Natl. Acad. Sci. U.S.A. 112, 13982-13987 (2015)
73.
Xia, Y. et al.: Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis. Gastroenterology 150, 194-205 (2015)
74.
Boettcher, S.* et al.: Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood 124, 1393-1403 (2014)
75.
Eisele, Y.S.* et al.: Multiple factors contribute to the peripheral induction of cerebral β-amyloidosis. J. Neurosci. 34, 10264-10273 (2014)
76.
Franceschi, V.* et al.: In vivo image analysis of BoHV-4-based vector in mice. PLoS ONE 9:e95779 (2014)
77.
Gautheron, J.* et al.: A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol. Med. 6, 1062-1074 (2014)
78.
Gewies, A.* et al.: Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation. Cell Rep. 9, 1292-1305 (2014)
79.
Heikenwälder, M. & Protzer, U.: LINE(1)s of evidence in HBV-driven liver cancer. Cell Host Microbe 15, 249-250 (2014)
80.
Hösel, M.* et al.: Hepatitis B virus infection enhances susceptibility towards adeno-associated viral vector transduction in vitro and in vivo. Hepatology 59, 2110-2120 (2014)